{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:52:08Z","timestamp":1791229928373,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.breast.2022.11.009","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T20:21:44Z","timestamp":1670012504000},"page":"332-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL"],"prefix":"10.1016","volume":"66","author":[{"given":"Benedetto","family":"Longo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Di Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Felici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"D'orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Giacalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Storti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Cervelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.breast.2022.11.009_bib3","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.breast.2022.11.009_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/PRS.0000000000003933","article-title":"MBN 2016 aesthetic breast meeting BIA-ALCL consensus conference report","volume":"141","author":"Nava","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.breast.2022.11.009_bib5","first-page":"sjac133","article-title":"Practice recommendation updates from the World consensus conference on BIA-ALCL","author":"Santanelli di Pompeo","year":"2022","journal-title":"Aestet Surg. J."},{"key":"10.1016\/j.breast.2022.11.009_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104982","article-title":"Final opinion on the safety of breast implants in relation to anaplastic large cell lymphoma: report of the scientific committee on health, emerging and environmental risks (SCHEER)","volume":"125","author":"De Jong","year":"2021","journal-title":"Regul Toxicol Pharmacol"},{"issue":"2","key":"10.1016\/j.breast.2022.11.009_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejso.2020.07.043","volume":"47","author":"Turton","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2022.11.009_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006534-199708000-00065","article-title":"Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant","volume":"100","author":"Keech","year":"1997","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.breast.2022.11.009_bib12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bjps.2019.11.064","article-title":"Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants","volume":"73","author":"Cordeiro","year":"2020","journal-title":"J Plast Reconstr Aesthetic Surg"},{"issue":"2","key":"10.1016\/j.breast.2022.11.009_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/PRS.0000000000008155","article-title":"An unusual case of BIA-ALCL associated with prolonged\/complicated biocell-textured expander, followed by smooth round breast implant exposure, and concurrent use of adalimumab","volume":"148","author":"Akhavan","year":"2021","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.breast.2022.11.009_bib15","series-title":"What is missing from the 2022 practice recommendation updates from the World consensus conference on BIA-ALCL? [published online ahead of print, 2022 oct 26]","first-page":"sjac274","author":"Mercer","year":"2022"},{"issue":"1","key":"10.1016\/j.breast.2022.11.009_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bjps.2020.10.001","article-title":"Moving breast implant registries forward: are they FAIR and Functional?","volume":"74","author":"Bargon","year":"2021","journal-title":"J Plast Reconstr Aesthetic Surg"},{"issue":"5","key":"10.1016\/j.breast.2022.11.009_bib17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/PRS.0000000000003233","article-title":"Global adverse event reports of breast implant-associated ALCL: an international review of 40 government authority databases","volume":"139","author":"Srinivasa","year":"2017","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.breast.2022.11.009_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoncol.2017.4510","article-title":"Breast implants and the risk of anaplastic large-cell lymphoma in the breast","volume":"4","author":"de Boer","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2022.11.009_bib19","doi-asserted-by":"crossref","first-page":"11e","DOI":"10.1097\/PRS.0000000000003916","article-title":"22 cases of breast implant-associated ALCL: awareness and outcome tracking from the Italian Ministry of health","volume":"141","author":"Campanale","year":"2018","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.breast.2022.11.009_bib20","doi-asserted-by":"crossref","first-page":"530e","DOI":"10.1097\/PRS.0000000000007240","article-title":"The crucial role of surgical treatment in BIA-ALCL prognosis in early- and advanced-stage patients","volume":"146","author":"Campanale","year":"2020","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.breast.2022.11.009_bib21","author":"Ministero della Salute"},{"key":"10.1016\/j.breast.2022.11.009_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejca.2021.01.041","article-title":"Chest wall infiltration is a critical prognostic factor in breast implant-associated anaplastic large-cell lymphoma affected patients","volume":"148","author":"Campanale","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2022.11.009_bib24","first-page":"1161","article-title":"Breast implant associated anaplastic large cell lymphoma (BIA-ALCL)","volume":"152","author":"Perry","year":"2020","journal-title":"Am Surg"},{"key":"10.1016\/j.breast.2022.11.009_bib25","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/PRS.0000000000003233","article-title":"Global adverse event reports of breast implant-associated ALCL: an international review of 40 government authority databases","volume":"139","author":"Srinivasa","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.breast.2022.11.009_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41379-018-0130-7","article-title":"Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomas","volume":"32","author":"Di Napoli","year":"2019","journal-title":"Mod Pathol"},{"issue":"24","key":"10.1016\/j.breast.2022.11.009_bib27","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.3390\/cancers13246174","article-title":"RNA sequencing of primary cutaneous and breast-implant associated anaplastic large cell lymphomas reveals infrequent fusion transcripts and upregulation of PI3K\/AKT signaling via neurotrophin pathway genes","volume":"13","author":"Di Napoli","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.breast.2022.11.009_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104982","article-title":"Final opinion on the safety of breast implants in relation to anaplastic large cell lymphoma: report of the scientific committee on health, emerging and environmental risks (SCHEER)","volume":"125","author":"De Jong","year":"2021","journal-title":"Regul Toxicol Pharmacol"},{"issue":"5","key":"10.1016\/j.breast.2022.11.009_bib29","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ejso.2020.10.029","article-title":"Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)","volume":"47","author":"Rond\u00f3n-Lagos","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2022.11.009_bib30","series-title":"Increased prevalence of BRCA1\/2 mutations in women with macro-textured breast implants and anaplastic large cell lymphoma of the breast","author":"De Boer","year":"2020"},{"key":"10.1016\/j.breast.2022.11.009_bib31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/his.12737","article-title":"Breast implantassociated anaplastic large cell lymphoma in a patient with Li-Fraumeni syndrome","volume":"67","author":"Lee","year":"2015","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.breast.2022.11.009_bib32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.clbc.2013.08.009","article-title":"Implant-associated primary anaplastic large-cell lymphoma with simultaneous involvement of bilateral breast capsules","volume":"13","author":"Bautista-Quach","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2022.11.009_bib33","article-title":"Increasing evidence for the association of breast implant-associated anaplastic large cell lymphoma and Li fraumeni syndrome","volume":"2019","author":"Adlard","year":"2019","journal-title":"Case Rep Genet"},{"issue":"10","key":"10.1016\/j.breast.2022.11.009_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10102082","article-title":"The state of the art about etiopathogenetic models on breast implant associated-anaplastic large cell lymphoma (BIA-ALCL): a narrative review","volume":"10","author":"Cuomo","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.breast.2022.11.009_bib35","doi-asserted-by":"crossref","first-page":"30e","DOI":"10.1097\/PRS.0000000000007423","article-title":"Cellular and molecular mechanisms of breast implant-associated anaplastic large cell lymphoma","volume":"147","author":"DeCoster","year":"2021","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"10.1016\/j.breast.2022.11.009_bib36","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.3390\/cancers12123861","article-title":"Etiology of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): current directions in research","volume":"12","author":"Deva","year":"2020","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.breast.2022.11.009_bib37","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.3390\/cancers13215298","article-title":"Gram-negative bacterial lipopolysaccharide promotes tumor cell proliferation in breast implant-associated anaplastic large-cell lymphoma","volume":"13","author":"Mempin","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.breast.2022.11.009_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13000-018-0688-x","article-title":"Breast implant-associated anaplastic large cell lymphoma in a Li-Fraumeni patient: a case report","volume":"13","author":"Pastorello","year":"2018","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.breast.2022.11.009_bib39","article-title":"Current progress in breast implant-associated anaplastic large cell lymphoma","volume":"11","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.breast.2022.11.009_bib40","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3324\/haematol.2019.245860","article-title":"Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma","volume":"106","author":"Oishi","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.breast.2022.11.009_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpra.2022.01.004","article-title":"Primary lymphomas of the breast: a review","volume":"32","author":"James","year":"2022","journal-title":"JPRAS Open"},{"key":"10.1016\/j.breast.2022.11.009_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153589","article-title":"Breast implant-associated EBV-positive diffuse large B-cell lymphoma: two case reports and literature review","volume":"226","author":"Morgan","year":"2021","journal-title":"Pathol Res Pract"},{"issue":"4","key":"10.1016\/j.breast.2022.11.009_bib43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/SAP.0000000000002537","article-title":"Epstein-barr virus-associated diffuse large B-cell lymphoma identified in a breast implant capsule: a new breast implant-associated lymphoma?","volume":"86","author":"Malata","year":"2021","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.breast.2022.11.009_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151512","article-title":"B-cell lymphomas associated with breast implants: report of three cases and review of the literature","volume":"46","author":"Evans","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.breast.2022.11.009_bib45","article-title":"A rare case of breast implant-associated diffuse large B-cell lymphoma","volume":"2019","author":"Larrimore","year":"2019","journal-title":"Case Rep Oncol Med"},{"issue":"8","key":"10.1016\/j.breast.2022.11.009_bib46","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.3324\/haematol.2019.232355","article-title":"Breast implant-associated Epstein-Barr virus-positive large B-cell lymphomas: a report of three cases","volume":"105","author":"Rodr\u00edguez-Pinilla","year":"2020","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.breast.2022.11.009_bib47","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41379-021-00842-6","article-title":"Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease","volume":"34","author":"Evans","year":"2021","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.breast.2022.11.009_bib48","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/asj\/sjy331","article-title":"NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)","volume":"39","author":"Clemens","year":"2019","journal-title":"Aesthetic Surg J"},{"issue":"1","key":"10.1016\/j.breast.2022.11.009_bib49","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3126\/nje.v12i1.42975","article-title":"Non-Hodgkin's lymphoma Breast in a lactating mother: case Report","volume":"12","author":"Rathee","year":"2022","journal-title":"Nepal J Epidemiol"},{"key":"10.1016\/j.breast.2022.11.009_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/20363613211028498","article-title":"Breast erythema and nodular skin metastasis as the first manifestation of breast implant-associated anaplastic large cell lymphoma","volume":"13","author":"Ducastel","year":"2021","journal-title":"Rare Tumors"},{"key":"10.1016\/j.breast.2022.11.009_bib51","article-title":"Breast implant-associated anaplastic large cell lymphoma: two distinct clinical presentations [published online ahead of print, 2022 may 18]","author":"Miranda","year":"2022","journal-title":"Acta Med Port"},{"issue":"2","key":"10.1016\/j.breast.2022.11.009_bib52","first-page":"160","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma [published correction appears in J clin oncol","volume":"34","author":"Clemens","year":"2016","journal-title":"DiNapoli, Arianna [corrected to Di Napoli, Arianna]]. J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2022.11.009_bib53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","article-title":"Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients","volume":"32","author":"Miranda","year":"2014","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2022.11.009_bib54","doi-asserted-by":"crossref","first-page":"NP68","DOI":"10.1093\/asj\/sjx237","article-title":"Why the micromort concept falls short in breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) risk analysis","volume":"38","author":"Swanson","year":"2018","journal-title":"Aesthetic Surg J"},{"key":"10.1016\/j.breast.2022.11.009_bib55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.breast.2019.05.005","article-title":"About the French prohibition of textured breast implants: is it justified or over-cautious? The EUSOMA, ESSO\/BRESSO position [published correction appears in Breast","volume":"46","author":"Cardoso","year":"2019","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.breast.2022.11.009_bib56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/2292550320925906","article-title":"Breast implant-associated anaplastic large-cell lymphoma: current understanding and recommendations for management","volume":"28","author":"St Cyr","year":"2020","journal-title":"Plast Surg (Oakv)"},{"issue":"10","key":"10.1016\/j.breast.2022.11.009_bib57","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1200\/JCO.19.02778","article-title":"Best practices guideline for the pathologic diagnosis of breast implant-associated anaplastic large-cell lymphoma","volume":"38","author":"Jaffe","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2022.11.009_bib58","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1097\/PRS.0000000000005565","article-title":"Achieving reliable diagnosis in late breast implant seromas: from reactive to anaplastic large cell lymphoma","volume":"143","author":"Di Napoli","year":"2019","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"10.1016\/j.breast.2022.11.009_bib59","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41379-021-00863-1","article-title":"Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship","volume":"34","author":"Medeiros","year":"2021","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.breast.2022.11.009_bib60","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.2011.08651.x","article-title":"Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma)","volume":"153","author":"Dearden","year":"2011","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.breast.2022.11.009_bib61","doi-asserted-by":"crossref","first-page":"227e","DOI":"10.1097\/PRS.0000000000006362","article-title":"The dishonesty of referring to total intact capsulectomy as \"en bloc\" resection or capsulectomy","volume":"145","author":"Gerzenshtein","year":"2020","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.breast.2022.11.009_bib62","article-title":"Stepwise en bloc resection of breast implant-associated anaplastic large cell lymphoma with oncologic considerations","volume":"1","author":"Tevis","year":"2019","journal-title":"Aesthet Surg J Open Forum"},{"issue":"3","key":"10.1016\/j.breast.2022.11.009_bib63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/asj\/sjw259","article-title":"NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma","volume":"37","author":"Clemens","year":"2017","journal-title":"Aesthetic Surg J"},{"issue":"18","key":"10.1016\/j.breast.2022.11.009_bib64","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1182\/blood-2018-03-785972","article-title":"How I treat breast implant-associated anaplastic large cell lymphoma","volume":"132","author":"Mehta-Shah","year":"2018","journal-title":"Blood"},{"issue":"10168","key":"10.1016\/j.breast.2022.11.009_bib65","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial [published correction appears in Lancet","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.breast.2022.11.009_bib66","article-title":"Barbara Pro, Tim Illidge, et al. The Echelon-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma","volume":"136","author":"Horwitz","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.breast.2022.11.009_bib67","series-title":"Breast implant-associated ALCL","year":"2020"},{"issue":"9","key":"10.1016\/j.breast.2022.11.009_bib68","article-title":"Stage IV breast implant-associated anaplastic large-cell lymphoma with complete pathologic response to neoadjuvant chemotherapy","volume":"7","author":"Thibodeau","year":"2019","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"4","key":"10.1016\/j.breast.2022.11.009_bib69","doi-asserted-by":"crossref","first-page":"586e","DOI":"10.1097\/PRS.0000000000004262","article-title":"How to diagnose and treat breast implant-associated anaplastic large cell lymphoma","volume":"141","author":"Clemens","year":"2018","journal-title":"Plast Reconstr Surg"},{"issue":"3S","key":"10.1016\/j.breast.2022.11.009_bib70","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1097\/PRS.0000000000005569","article-title":"Breast reconstruction following breast implant-associated anaplastic large cell lymphoma","volume":"143","author":"Lamaris","year":"2019","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.breast.2022.11.009_bib71","doi-asserted-by":"crossref","first-page":"v108","DOI":"10.1093\/annonc\/mdv201","article-title":"Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"d'Amore","year":"2015","journal-title":"Ann Oncol : official journal of the European Society for Medical Oncology"},{"issue":"6","key":"10.1016\/j.breast.2022.11.009_bib72","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00266-014-0406-3","article-title":"Total breast reconstruction using autologous fat grafting following nipple-sparing mastectomy in irradiated and non-irradiated patients","volume":"38","author":"Longo","year":"2014","journal-title":"Aesthetic Plast Surg"},{"issue":"3","key":"10.1016\/j.breast.2022.11.009_bib73","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00266-015-0475-y","article-title":"Breast reconstruction with delayed fat-graft-augmented DIEP flap in patients with insufficient donor-site volume","volume":"39","author":"Laporta","year":"2015","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.breast.2022.11.009_bib74","doi-asserted-by":"crossref","first-page":"14","DOI":"10.57604\/PRRS-002","article-title":"Recurrent dermatofibrosarcoma protuberans of the clavicular region: radical excision and reconstruction with Latissimus Dorsi myocutaneous flap","volume":"1","author":"Longo","year":"2022","journal-title":"PRRS"},{"key":"10.1016\/j.breast.2022.11.009_bib75","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0000000000010480","article-title":"Secondary breast reconstruction in small to medium-sized irradiated breasts: could fat-augmented LD (FALD) flap be a reliable alternative?","author":"Longo","year":"2023","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.breast.2022.11.009_bib76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.21037\/gs.2016.11.03","article-title":"Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules","volume":"6","author":"Clemens","year":"2017","journal-title":"Gland Surg"},{"issue":"4","key":"10.1016\/j.breast.2022.11.009_bib77","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/PRS.0000000000007784","article-title":"Not all breast explants are equal: contemporary strategies in breast explantation surgery","volume":"147","author":"Tanna","year":"2021","journal-title":"Plast Reconstr Surg"},{"issue":"7","key":"10.1016\/j.breast.2022.11.009_bib78","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/asj\/sjz343","article-title":"Is banning texturized implants to prevent breast implant-associated anaplastic large cell lymphoma a rational decision? A meta-analysis and cost-effectiveness study","volume":"40","author":"Danilla","year":"2020","journal-title":"Aesthetic Surg J"},{"key":"10.1016\/j.breast.2022.11.009_bib82","doi-asserted-by":"crossref","first-page":"e2466","DOI":"10.1097\/GOX.0000000000002466","article-title":"Breast implant surfaces and their impact on current practices: where we are now and where are we going?","volume":"7","author":"Munhoz","year":"2019","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"10.1016\/j.breast.2022.11.009_bib83","doi-asserted-by":"crossref","DOI":"10.21037\/abs-20-96","article-title":"Current risk of breast implant-associated anaplastic large cell lymphoma: a systematic review of epidemiological studies","volume":"5","author":"Lynch","year":"2021","journal-title":"Annals Of Breast Surgery"},{"key":"10.1016\/j.breast.2022.11.009_bib84","article-title":"Breast implants\u2014certain labeling recommendations to improve patient communication","year":"2020","journal-title":"Food and Drug Administration"},{"issue":"3","key":"10.1016\/j.breast.2022.11.009_bib85","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00006534-199803000-00039","article-title":"Aesthetic management of the breast following explantation: evaluation and mastopexy options","volume":"101","author":"Beran","year":"1998","journal-title":"Plast Reconstr Surg: Mar"},{"issue":"3","key":"10.1016\/j.breast.2022.11.009_bib86","doi-asserted-by":"crossref","first-page":"ojz025","DOI":"10.1093\/asjof\/ojz025","article-title":"Management of asymptomatic patients with textured surface breast implants","volume":"1","author":"McGuire","year":"2019","journal-title":"Aesthet Surg J Open Forum"},{"key":"10.1016\/j.breast.2022.11.009_bib88","doi-asserted-by":"crossref","first-page":"34","DOI":"10.57604\/PRRS-005","article-title":"National Breast Implant Registry in Italy. Competent authority perspective to improve patients' safety","volume":"1","author":"Campanale","year":"2022","journal-title":"PRRS"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622001928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622001928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:48:17Z","timestamp":1760777297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977622001928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":77,"alternative-id":["S0960977622001928"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2022.11.009","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2022.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}